Literature DB >> 22488545

Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.

Laura Murcia, Bartolomé Carrilero, Pedro Albajar Viñas, Manuel Segovia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22488545

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN： 0214-3429            Impact factor:   1.553


× No keyword cloud information.
  4 in total

1.  Transmission of Chagas disease via blood transfusions in 2 immunosuppressed pigtailed macaques (Macaca nemestrina).

Authors:  Derek L Fong; Annie E Torrence; Keith W Vogel; Diane E Stockinger; Veronica Nelson; Robert D Murnane; Audrey Baldessari; LaRene Kuller; Michael Agy; Hans-Peter Kiem; Charlotte E Hotchkiss
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

2.  Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment.

Authors:  Cynthia Santamaria; Eric Chatelain; Yves Jackson; Qianqian Miao; Brian J Ward; François Chappuis; Momar Ndao
Journal:  BMC Infect Dis       Date:  2014-06-03       Impact factor: 3.090

3.  Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease.

Authors:  Yves Jackson; Baptiste Wyssa; François Chappuis
Journal:  J Antimicrob Chemother       Date:  2020-03-01       Impact factor: 5.790

4.  Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021.

Authors:  Andrew Abbott; Susan P Montgomery; Rebecca J Chancey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-03-11       Impact factor: 17.586
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.